NACE-ABC REGIONAL PROGRAMS: Emerging Challenges in Primary Care 2019 – Ft. Lauderdale, FL
Saturday, September 7, 2019
Fort Lauderdale Marriott Coral Springs
11775 Heron Bay Blvd.
Coral Springs, FL 33076
(954) 753-5598
There is no registration fee for this activity.
REGISTERSpecial Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.
Event Parking
Complimentary self-parking is available at the hotel.
Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.
We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.
Please join us and become an active participant in this one-day learning community of your peers.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Summarize the pathophysiology and risk factors for acne vulgaris; Describe the clinical presentation of acne vulgaris; Outline treatment approaches to mild, moderate and severe acne; Discuss strategies to prevent scarring in patients with acne vulgaris.
- Describe nocturia’s impact on affected patients; Evaluate symptoms of Nocturia in affected patients in order to determine the source of symptoms; Assess current pharmacologic and non-pharmacologic nocturia
- Evaluate the physiological role of GLP-1 and associated implications for the treatment of patients with Diabetes; Review recommendations from current diabetes guidelines regarding the use of GLP-1 receptor agonists; Determine the advantages and disadvantages of individual GLP-1 receptor agonists in terms of efficacy, tolerability, dosing, frequency, and administration requirements; Assess the effect of GLP-1 receptor agonists on glycemic and extra-glycemic outcomes; Discuss strategies for reducing adverse effects in patients receiving GLP-1 receptor agonists.
- Appreciate the roles of altered gut motility, visceral hypersensitivity, and CNS influences in the pathogenesis of Irritable Bowel Syndrome (IBS); Know the Rome IV criteria for IBS diagnosis and appreciate the various subtypes of Irritable Bowel Syndrome; Integrate targeted therapies to effect an improvement in symptoms of IBS-C and IBS-D by appreciating the various medications’ mechanisms of
- Appreciate both structural and functional causes of dysphagia and know when to consider radiography or upper endoscopy; Understand the various diagnostic tests available for the evaluation of the patient with biliary colic and when these tests are necessary before possible surgical referral; Acknowledge the differences in presentation, prognosis, and management of patients presenting with abdominal pain.
Agenda*
Summary of Key Points and Closing Remarks
| 7:30 – 8:00 am | Continental Breakfast and Registration | |
| 8:00 – 8:10 | Welcome Remarks – Gregg Sherman, MD | |
| 8:10 – 9:20 | Acne 101 Mercedes E. Gonzalez, MD |
|
| 9:20 – 10:30 | Identification, Evaluation and Treatment of Nocturia in the Primary Care Setting in 2019 Matt T. Rosenberg, MD |
|
| 10:30 – 10:50 | Break | |
| 10:50 – 12:00 pm | A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How Dhiren Patel, PharmD, CDE, BC-ADM, BCACP |
|
| 12:00 – 1:10 | Lunch | |
| 1:10 – 2:20 | Managing Irritable Bowel Syndrome in Primary Care: Strategies for Success Jeffrey H. Schneider, MD |
|
| 2:20 – 3:30 | Practical GI Pearls: What Would You Do? Jeffrey H. Schneider, MD |
|
| 3:30 – 3:45 | Summary of Key Points and Closing Remarks |
*Agenda subject to change
Faculty
Mercedes E. Gonzalez, MD
Medical Director, Pediatric Dermatology of Miami
Clinical Assistant Professor, Dr. Phillip Frost Department of Dermatology
University of Miami Miller School of Medicine
Clinical Assistant Professor
Herbert Wertheim College of Medicine, Florida International University
Miami, FL
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP
Clinical Pharmacy Specialist – Endocrine
VA Boston Healthcare System
Adjunct Associate Professor of Pharmacy Practice
MCPHS University
Boston, MA
Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI
Jeffrey H. Schneider, MD
Clinical Assistant Professor, Dept of Internal Medicine NSU
Health Professions Division
Dr. Kiran C. Patel College of Osteopathic Medicine
Coral Springs, FL
Moderator
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL
Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education
Plantation, FL
Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education
Plantation, FL
Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA
Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA
John Guerriero, MBA
Director of Learning and Development
Med Learning Group
New York, NY
Ana Maria Albino
Program Manager
Med Learning Group
New York, NY
Lauren Welch, MA
Vice President, Outcomes and Accreditation
Med Learning Group
New York, NY
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 5.0 Contact hour(s) of continuing education, which includes 1.0 pharmacology hour.
Sponsored and Certified By
Med Learning Group and co-provided by Ultimate Medical Academy/CCM
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity was planned and produced in accordance with the ACCME Essentials.
Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in treating and managing patients with diabetes. CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Novo Nordisk; and in part by an educational grant from Ferring Pharmaceuticals, Inc.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Novo Nordisk; and in part by an educational grant from Ferring Pharmaceuticals, Inc.